XOMA to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Webcast on March 9 Feb 24, 2016 1:29pm EST
XOMA Announces License Agreement With Novo Nordisk for XMetA Program in Diabetes Dec 01, 2015 8:30am EST
XOMA Provides Corporate Update and Reports Financial Results for Third Quarter 2015 Nov 05, 2015 4:01pm EST
XOMA to Announce Third Quarter 2015 Financial Results and Host Webcast on November 5 Oct 29, 2015 1:37pm EDT
XOMA Initiates Proof-of-Concept Study for XOMA 358 in Patients with Congenital Hyperinsulinism Oct 26, 2015 8:30am EDT
XOMA Announces Development and Commercialization Agreement for First-in-Class Anti-TGF-beta Antibody Program in Immuno-Oncology Oct 01, 2015 7:30am EDT
